At the time of his initial glioblastoma diagnosis, Matthew Futer was given less than three months to live. Dr. David Baskin, a neurosurgeon at Houston Methodist, and his team knew that fighting this aggressive cancer meant leveraging a unique treatment option. Matthew has been cancer-free for over seven years thanks to an experimental gene therapy drug.